Open AccessP134 (0156) INDUCTION THERAPY WITH EVEROLIMUS IN COMBINATION WITH DHAP (DEXAMETHASONE, HIGH‐DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO‐CONTROLLED PHASE I/II TRIAL (HD‐R3I)
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547977.84027.90
Subject(s) - dhap , refractory (planetary science) , medicine , everolimus , placebo , dexamethasone , oncology , randomized controlled trial , pharmacology , chemistry , pathology , biology , biochemistry , alternative medicine , astrobiology , enzyme